Intravitreal anti-vascular endothelial growth factor monotherapy for large submacular hemorrhage secondary to neovascular age-related macular degeneration

PURPOSE: To evaluate the efficacy of anti-vascular endothelial growth factor (VEGF) monotherapy for large submacular hemorrhage (SMH) secondary to neovascular age-related macular degeneration (nAMD). METHODS: A total of 49 treatment-naive patients (49 eyes) with large SMH (more than five disc areas...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Eye (Lond)
Hlavní autoři: Kim, H S, Cho, H J, Yoo, S G, Kim, J H, Han, J I, Lee, T G, Kim, J W
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2015
Témata:
Clinical Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4565949/
https://ncbi.nlm.nih.gov/pubmed/26272443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2015.131
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky